Pfizer Inc Cdr Stock Price on June 1, 2023
PFE Stock | 12.40 0.02 0.16% |
If you're considering investing in Pfizer Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pfizer stands at 12.40, as last reported on the 27th of December, with the highest price reaching 12.42 and the lowest price hitting 12.25 during the day. Pfizer Inc CDR maintains Sharpe Ratio (i.e., Efficiency) of -0.0643, which implies the firm had a -0.0643% return per unit of risk over the last 3 months. Pfizer Inc CDR exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pfizer's Coefficient Of Variation of (1,358), risk adjusted performance of (0.05), and Variance of 2.3 to confirm the risk estimate we provide.
Pfizer reported last year Sale Purchase Of Stock of (2 Billion). As of the 27th of December 2024, Stock Based Compensation is likely to grow to about 945.1 M, while Total Stockholder Equity is likely to drop about 82.8 B. . Pfizer Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Pfizer |
Sharpe Ratio = -0.0643
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PFE |
Estimated Market Risk
1.55 actual daily | 13 87% of assets are more volatile |
Expected Return
-0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pfizer is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pfizer by adding Pfizer to a well-diversified portfolio.
Price Book 1.5597 | Enterprise Value Ebitda 15.0477 | Price Sales 3.6394 | Shares Float 5.7 B | Dividend Share 1.67 |
Pfizer Main Headline on 1st of June 2023
U.S. FDA Approves ABRYSVO, Pfizers Vaccine for the Preventio... by news.google.com
U.S. FDA Approves ABRYSVO, Pfizers Vaccine for the Prevention of Respiratory Syncytial Virus in Older Adults Marketscreener.com
Pfizer Valuation on June 1, 2023
It is possible to determine the worth of Pfizer on a given historical date. On June 1, 2023 Pfizer was worth 16.61 at the beginning of the trading date compared to the closed value of 16.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pfizer stock. Still, in general, we apply an absolute valuation method to find Pfizer's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pfizer where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pfizer's related companies.
Open | High | Low | Close | Volume | |
16.17 | 16.65 | 16.10 | 16.60 | 8,581 | |
06/01/2023 | 16.61 | 16.65 | 16.48 | 16.56 | 16,049 |
16.63 | 16.86 | 16.63 | 16.75 | 28,623 |
Backtest Pfizer | | | Pfizer History | | | Pfizer Valuation | Previous | Next |
Pfizer Trading Date Momentum on June 1, 2023
On June 02 2023 Pfizer Inc CDR was traded for 16.75 at the closing time. The highest price during the trading period was 16.86 and the lowest recorded bid was listed for 16.63 . The volume for the day was 28.6 K. This history from June 2, 2023 contributed to the next trading day price boost. The trading delta at closing time to the next closing price was 1.15% . The trading delta at closing time to the current price is 2.78% . |
Pfizer Inc CDR Fundamentals Correlations and Trends
By evaluating Pfizer's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pfizer's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pfizer financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pfizer Stock history
Pfizer investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pfizer is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pfizer Inc CDR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pfizer stock prices may prove useful in developing a viable investing in Pfizer
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 5.6 B | 4.5 B | |
Net Income Applicable To Common Shares | 36.1 B | 19.7 B |
Pfizer Stock Technical Analysis
Pfizer technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pfizer Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Pfizer Inc CDR cannot be verified against its exchange. Please verify the symbol is currently traded on NEO Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pfizer December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pfizer shares will generate the highest return on investment. By undertsting and applying Pfizer stock market strength indicators, traders can identify Pfizer Inc CDR entry and exit signals to maximize returns
Pfizer Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pfizer's price direction in advance. Along with the technical and fundamental analysis of Pfizer Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pfizer to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.14) | |||
Total Risk Alpha | (0.20) | |||
Treynor Ratio | (0.33) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in Pfizer Stock
Pfizer financial ratios help investors to determine whether Pfizer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pfizer with respect to the benefits of owning Pfizer security.